AU2351197A - Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith - Google Patents

Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Info

Publication number
AU2351197A
AU2351197A AU23511/97A AU2351197A AU2351197A AU 2351197 A AU2351197 A AU 2351197A AU 23511/97 A AU23511/97 A AU 23511/97A AU 2351197 A AU2351197 A AU 2351197A AU 2351197 A AU2351197 A AU 2351197A
Authority
AU
Australia
Prior art keywords
liver disorders
prevention
treatment
associated therewith
complications associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23511/97A
Other languages
English (en)
Inventor
Martin Bickel
Holger Heitsch
Max Hropot
Adalbert Wagner
Klaus Wirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2351197A publication Critical patent/AU2351197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU23511/97A 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith Abandoned AU2351197A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19620509 1996-05-22
DE19632042 1996-08-08
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303 1996-09-25
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
AU2351197A true AU2351197A (en) 1997-11-27

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23511/97A Abandoned AU2351197A (en) 1996-05-22 1997-05-20 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Country Status (23)

Country Link
US (1) US5786365A (https=)
EP (2) EP0808627A2 (https=)
JP (1) JP4034849B2 (https=)
CN (1) CN1176102A (https=)
AT (1) ATE189389T1 (https=)
AU (1) AU2351197A (https=)
BR (1) BR9703367A (https=)
CA (1) CA2205780A1 (https=)
CZ (1) CZ154697A3 (https=)
DE (1) DE59701078D1 (https=)
DK (1) DK0808628T3 (https=)
ES (1) ES2144291T3 (https=)
GR (1) GR3033048T3 (https=)
HR (1) HRP970278A2 (https=)
HU (1) HUP9700913A1 (https=)
ID (1) ID18447A (https=)
IL (1) IL120862A0 (https=)
NO (1) NO972311L (https=)
PL (1) PL320134A1 (https=)
PT (1) PT808628E (https=)
SI (1) SI0808628T1 (https=)
SK (1) SK63097A3 (https=)
TR (1) TR199700392A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740543B2 (en) * 1996-12-20 2001-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg New aqueous medicament preparations for the production of propellent gas-free aerosols

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
EP1044012B1 (en) 1998-11-10 2006-05-03 Temple University of the Commonwealth System of Higher Education Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5
AU773862B2 (en) * 1998-11-10 2004-06-10 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
RU2006124843A (ru) 2003-12-12 2008-01-20 Уайт (Us) Хинолины, пригодные для лечения сердечно-сосудистого заболевания
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
WO2012006103A2 (en) 2010-06-29 2012-01-12 Jennifer Digrazia Wound and bandage protection system and method
US12427067B2 (en) 2010-06-29 2025-09-30 Jennifer DiGrazia Wound and bandage protection system and method
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (en) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740543B2 (en) * 1996-12-20 2001-11-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg New aqueous medicament preparations for the production of propellent gas-free aerosols

Also Published As

Publication number Publication date
ID18447A (id) 1998-04-09
HU9700913D0 (en) 1997-07-28
MX9703725A (es) 1997-11-29
SI0808628T1 (en) 2000-04-30
HUP9700913A1 (hu) 1999-09-28
CA2205780A1 (en) 1997-11-22
SK63097A3 (en) 1997-12-10
US5786365A (en) 1998-07-28
NO972311D0 (no) 1997-05-21
ATE189389T1 (de) 2000-02-15
EP0808628A2 (de) 1997-11-26
JP4034849B2 (ja) 2008-01-16
IL120862A0 (en) 1997-09-30
PL320134A1 (en) 1997-11-24
DK0808628T3 (da) 2000-06-26
CN1176102A (zh) 1998-03-18
DE59701078D1 (de) 2000-03-09
EP0808627A2 (de) 1997-11-26
GR3033048T3 (en) 2000-08-31
CZ154697A3 (en) 1997-12-17
HRP970278A2 (en) 1998-04-30
TR199700392A2 (xx) 1997-12-21
EP0808628B1 (de) 2000-02-02
BR9703367A (pt) 1998-09-15
NO972311L (no) 1997-11-24
PT808628E (pt) 2000-05-31
EP0808628A3 (de) 1998-01-14
JPH1045624A (ja) 1998-02-17
ES2144291T3 (es) 2000-06-01

Similar Documents

Publication Publication Date Title
AU2351197A (en) Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith
AU6500298A (en) Derivatives of azetidine and pyrrolidine
EP0454501A3 (en) Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
DK0620215T3 (da) 1H-indol-3-acetamidderivater som sPLA2-inhibitorer
NO931401D0 (no) Steroidderivater for behandling av prostatahypertrofi, samt fremstilling og anvendelse derav
AU2215588A (en) Substituted cycloalkanols
PL350775A1 (en) Pharmaceutical compounds
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
ATE284692T1 (de) Verwendung von nicht-peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimerischen krankheit
DK0838223T3 (da) Hjerneødeminhibitor
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
IL88740A0 (en) Compositions for the inhibition of viruses
NO975903D0 (no) N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger
ES2188260T3 (es) 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.
EP0285284A3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
DE60027204D1 (en) Benzamidinderivate
ZA987963B (en) Disubstituted trans-3,4,4a,5,6,10b-haxahydro-2H-naphth(1,2-b)-1,4-oxazines a process for their preparation and pharmaceutical compositions containing them
AU2788797A (en) Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.